As a result, RNF144 promotes LUAD, gastric cancer, ovarian cancer, endometrial cancer, leukemia, and lymphoma and inhibits LUAD, HCC, ovarian cancer, and breast cancer. This evidence concerns the gene RNF144A and breast cancer.